Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration.
Pea
F
F
Brollo
L
L
Lugano
M
M
Dal Pos
L
L
Furlanut
M
M
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D015377:Cilastatin / Q000494:pharmacology; D000077728:Cilastatin, Imipenem Drug Combination; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D016903:Drug Monitoring; D006440:Hemofiltration; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D016030:Kidney Transplantation; D008297:Male; D009102:Multiple Organ Failure / Q000150:complications; D018805:Sepsis / Q000150:complications; D012709:Serum Albumin / Q000172:deficiency*; D017334:Teicoplanin / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D012709:Serum Albumin; D015377:Cilastatin; D017334:Teicoplanin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination